Abstract
The main objective of the current study was to synthesize, characterize, and application of an anticancer agent based on iron oxide nanoparticles (NPs) synthesized in the presence of berbamine and alginate to modulate the pre-metastatic ecological niche of human bladder cancer cells by inducing ROS-mediated mitochondrial depolarization. The environmentally friendly synthesized nanoparticles were analyzed using SEM and TEM imaging, VSM, XRD, DLS, Zeta sizing, photoluminescence, EDX, and UV–Vis spectroscopy techniques. The findings indicated that the nanoparticles were smaller than 100 nm, displayed consistent spherical morphology, and were evenly monodispersed in size. We observed that the hydrodynamic size of the synthesized NPs was around 247.8 nm and the zeta potential was −32.1 mV. EDX analysis showed that the fabricated NPs composed of Iron (70.9 % of Mass) and O (29.1 % of Mass). The XRD analysis showed that the pattern of the NPs is matched with JCPDS card number 82–1533. The VSM analysis revealed that the NPs displayed superparamagnetic properties when exposed to a magnetic field. Results from the anticancer investigations demonstrated that the NPs caused a dose and time-dependent lethal impact on T24 cells, while showing no significant toxicity on SV-HUC-1 cells, highlighting their biocompatibility. The anticancer mechanism was evaluated using acridine orange/ethidium bromide, DCFH-DA, JC-1 staining, and wound-healing/scratch assay. The results demonstrated that the cells underwent apoptosis instead of necrosis, attributed to ROS-triggered mitochondrial depolarization. Additionally, the nanoparticles inhibited the cells' migratory capabilities. These results suggest that the environmentally friendly produced iron nanoparticles have promising potential as a strong anticancer treatment.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call